See also this year's filing and all EDGAR filings for this company.
PDF Report 0001082554_2021_United_Therapeutics_Corp.pdf
Logs
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001082554, United Therapeutics Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,167,200,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 731,600,000 |
| 3 | remainder_Assets | 1,716,200,000 |
| 4 | LiabilitiesCurrent | 323,300,000 |
| 5 | LiabilitiesNoncurrent | 96,500,000 |
| 6 | remainder_Liabilities | 800,000,000 |
| 7 | CostOfGoodsAndServicesSold | 110,483,714 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 848,465,394 |
| 10 | remainder_Expenses | 471,324,681 |
| 11 | remainder_Revenues | 1,507,830,760 |
| 12 | remainder_NetIncome | 38,478,161 |
| 13 | remainder_ComprehensiveNetIncome | -3,754,917 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,615,000,000 |
| 1 | Liabilities | 1,219,800,000 |
| 2 | Expenses | 1,430,273,789 |
| 3 | Revenues | 1,507,830,760 |
| 4 | StockholdersEquity | 3,395,200,000 |
| 5 | NetIncome | 116,035,132 |
| 6 | ComprehensiveNetIncome | 114,157,674 |
| 7 | BaseVar | 4,407,568,814 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.58 |
| 9 | EconomicCapitalRatio | 3.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
